- Home
- ORIC vs LTBR Comparison
ORIC vs LTBR Comparison
Compare ORIC & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- LTBR
- Stock Information
- Founded
- ORIC 2014
- LTBR 1992
- Country
- ORIC United States
- LTBR United States
- Employees
- ORIC N/A
- LTBR N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- LTBR Professional Services
- Sector
- ORIC Health Care
- LTBR Consumer Discretionary
- Exchange
- ORIC Nasdaq
- LTBR Nasdaq
- Market Cap
- ORIC 362.9M
- LTBR 326.6M
- IPO Year
- ORIC 2020
- LTBR N/A
- Fundamental
- Price
- ORIC $10.21
- LTBR $12.80
- Analyst Decision
- ORIC Strong Buy
- LTBR
- Analyst Count
- ORIC 8
- LTBR 0
- Target Price
- ORIC $18.83
- LTBR N/A
- AVG Volume (30 Days)
- ORIC 1.2M
- LTBR 2.0M
- Earning Date
- ORIC 08-11-2025
- LTBR 07-30-2025
- Dividend Yield
- ORIC N/A
- LTBR N/A
- EPS Growth
- ORIC N/A
- LTBR N/A
- EPS
- ORIC N/A
- LTBR N/A
- Revenue
- ORIC N/A
- LTBR N/A
- Revenue This Year
- ORIC N/A
- LTBR N/A
- Revenue Next Year
- ORIC N/A
- LTBR N/A
- P/E Ratio
- ORIC N/A
- LTBR N/A
- Revenue Growth
- ORIC N/A
- LTBR N/A
- 52 Week Low
- ORIC $3.90
- LTBR $2.24
- 52 Week High
- ORIC $14.67
- LTBR $17.70
- Technical
- Relative Strength Index (RSI)
- ORIC 63.99
- LTBR 47.70
- Support Level
- ORIC $10.05
- LTBR $12.90
- Resistance Level
- ORIC $10.99
- LTBR $14.10
- Average True Range (ATR)
- ORIC 0.60
- LTBR 0.99
- MACD
- ORIC -0.07
- LTBR -0.24
- Stochastic Oscillator
- ORIC 54.67
- LTBR 26.30
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.